187 related articles for article (PubMed ID: 30483749)
1. Dexmedetomidine attenuates the toxicity of β‑amyloid on neurons and astrocytes by increasing BDNF production under the regulation of HDAC2 and HDAC5.
Wang Y; Jia A; Ma W
Mol Med Rep; 2019 Jan; 19(1):533-540. PubMed ID: 30483749
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine had neuroprotective effects on hippocampal neuronal cells via targeting lncRNA SHNG16 mediated microRNA-10b-5p/BDNF axis.
Wang L; Liu W; Zhang Y; Hu Z; Guo H; Lv J; Du H
Mol Cell Biochem; 2020 Jun; 469(1-2):41-51. PubMed ID: 32323054
[TBL] [Abstract][Full Text] [Related]
3. Harpagoside ameliorates the amyloid-β-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways.
Li J; Ding X; Zhang R; Jiang W; Sun X; Xia Z; Wang X; Wu E; Zhang Y; Hu Y
Neuroscience; 2015 Sep; 303():103-14. PubMed ID: 26135675
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effects Against Cerebral Ischemic Injury Exerted by Dexmedetomidine via the HDAC5/NPAS4/MDM2/PSD-95 Axis.
Lv H; Li Y; Cheng Q; Chen J; Chen W
Mol Neurobiol; 2021 May; 58(5):1990-2004. PubMed ID: 33411316
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors.
Durand D; Carniglia L; Turati J; Ramírez D; Saba J; Caruso C; Lasaga M
Neuropharmacology; 2017 Sep; 123():274-286. PubMed ID: 28495373
[TBL] [Abstract][Full Text] [Related]
6. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine pretreatment attenuates propofol‑induced neurotoxicity in neuronal cultures from the rat hippocampus.
Wei Y; Hu J; Liang Y; Zhong Y; He D; Qin Y; Li L; Chen J; Xiao Q; Xie Y
Mol Med Rep; 2016 Oct; 14(4):3413-20. PubMed ID: 27571870
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons.
Wu X; Chen PS; Dallas S; Wilson B; Block ML; Wang CC; Kinyamu H; Lu N; Gao X; Leng Y; Chuang DM; Zhang W; Lu RB; Hong JS
Int J Neuropsychopharmacol; 2008 Dec; 11(8):1123-34. PubMed ID: 18611290
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine attenuates the neurotoxicity of propofol toward primary hippocampal neurons in vitro via Erk1/2/CREB/BDNF signaling pathways.
Tu Y; Liang Y; Xiao Y; Lv J; Guan R; Xiao F; Xie Y; Xiao Q
Drug Des Devel Ther; 2019; 13():695-706. PubMed ID: 30858699
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against β-amyloid by targeting DAPK-1 and TP53.
Guo Y; Wu Y; Li N; Wang Z
Exp Mol Pathol; 2021 Feb; 118():104587. PubMed ID: 33275947
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine prevents Aβ25-35-induced cell death in cultured neuron by enhancing brain-derived neurotrophic factor release from astrocyte.
Luo G; Huang Y; Jia B; Zhang X; Mo D; Ma N; Gao F; Song L; Wang B; Miao Z
Neuroreport; 2018 Jan; 29(2):92-98. PubMed ID: 29120942
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine mitigates sevoflurane-induced cell cycle arrest in hippocampus.
Bo LJ; Yu PX; Zhang FZ; Dong ZM
J Anesth; 2018 Oct; 32(5):717-724. PubMed ID: 30128750
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Reduces Cognitive Impairment During Chronic Cerebral Hypoperfusion Through Brain-Derived Neurotrophic Factor Regulated by Epigenetic Modulation.
Wan Q; Ma X; Zhang ZJ; Sun T; Xia F; Zhao G; Wu YM
Mol Neurobiol; 2017 May; 54(4):2889-2900. PubMed ID: 27021024
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta up-regulates brain-derived neurotrophic factor production from astrocytes: rescue from amyloid beta-related neuritic degeneration.
Kimura N; Takahashi M; Tashiro T; Terao K
J Neurosci Res; 2006 Sep; 84(4):782-9. PubMed ID: 16862545
[TBL] [Abstract][Full Text] [Related]
16. ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation.
Sen A; Nelson TJ; Alkon DL
J Neurosci; 2015 May; 35(19):7538-51. PubMed ID: 25972179
[TBL] [Abstract][Full Text] [Related]
17. NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?
Croce N; Gelfo F; Ciotti MT; Federici G; Caltagirone C; Bernardini S; Angelucci F
Mol Cell Biochem; 2013 Apr; 376(1-2):189-95. PubMed ID: 23358924
[TBL] [Abstract][Full Text] [Related]
18. A role for astrocyte-derived amyloid β peptides in the degeneration of neurons in an animal model of temporal lobe epilepsy.
Kodam A; Ourdev D; Maulik M; Hariharakrishnan J; Banerjee M; Wang Y; Kar S
Brain Pathol; 2019 Jan; 29(1):28-44. PubMed ID: 29665128
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine alleviates cognitive impairment by promoting hippocampal neurogenesis via BDNF/TrkB/CREB signaling pathway in hypoxic-ischemic neonatal rats.
Chen X; Chen A; Wei J; Huang Y; Deng J; Chen P; Yan Y; Lin M; Chen L; Zhang J; Huang Z; Zeng X; Gong C; Zheng X
CNS Neurosci Ther; 2024 Jan; 30(1):e14486. PubMed ID: 37830170
[TBL] [Abstract][Full Text] [Related]
20. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]